reviewEuropean Journal of CancerNov 21, 2010Closed access

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

Clinique de Genolier · Institute of Social and Preventive Medicine · +12 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,074
total citations
FWCI
28.35
Percentile
100%
References
261
Citations per year

Authors

12

Topics & keywords

Keywords
  • Medicine
  • Pegfilgrastim
  • Febrile neutropenia
  • Filgrastim
  • Chemotherapy
  • Neutropenia
  • Granulocyte colony-stimulating factor
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.